FeesSafety
Pluang+

US House committee to review Bitcoin reserve bill with low odds of passing in 2026

Market News
15 Sep 2026
AMBCrypto
View Source
Neutral
US House committee to review Bitcoin reserve bill with low odds of passing in 2026

The US House Financial Services Committee will consider the American Reserve Modernization Act (ARMA) of 2026 on September 16, which proposes creating a strategic Bitcoin reserve. The bill aims to hold Bitcoin for at least 20 years and use future sales to reduce national debt, formalizing government management of digital assets seized from criminal cases. Despite holding 328,000 BTC, the US faces competition from other countries accumulating Bitcoin as a digital asset. However, due to a tight Congressional calendar and low political momentum, the bill's chances of passing before 2027 remain below 10%.

The US Bitcoin reserve bill faces low odds in Congress, with a chance below 10%, as of Sep 16, 2026 03:28 WIB. For readers following cryptocurrency market activity, here is Pluang's market snapshot as of Sep 16, 2026 03:28 WIB: out of 50 major cryptocurrencies priced on Pluang, 4 rose and 45 fell today. Notable movers include FIL (Filecoin) down 15.30%, XRP (Ripple) down 13.89%, and BAL (Balancer) up 11.14%.

More News

Genmab and Incyte launch trial combining petosemtamab and INCB161734 for KRAS G12D metastatic colorectal cancer.

Genmab and Incyte launch trial combining petosemtamab and INCB161734 for KRAS G12D metastatic colorectal cancer.

Genmab and Incyte announced a Phase 1/2 clinical trial to test a combination of petosemtamab, INCB161734, and standard chemotherapy as a first-line treatment for metastatic colorectal cancer with the KRAS G12D mutation. This mutation is common and li...

Company Fundamentals
Bullish
2 hours ago
Nanobiotix reports promising Phase 1 results for JNJ-1900 in advanced melanoma resistant to anti-PD-1 therapies

Nanobiotix reports promising Phase 1 results for JNJ-1900 in advanced melanoma resistant to anti-PD-1 therapies

Nanobiotix announced positive Phase 1 trial results for JNJ-1900 (NBTXR3), used with radiotherapy and immune checkpoint inhibitors, in 24 heavily pretreated advanced melanoma patients resistant to anti-PD-1 therapies. The treatment showed a 41.7% obj...

Company Fundamentals
Bullish
2 hours ago
SLB upgraded to bullish after Q3 beats and strong growth outlook through 2027.

SLB upgraded to bullish after Q3 beats and strong growth outlook through 2027.

SLB N.V. has been upgraded from neutral to bullish following its Q3 results, which showed better-than-expected revenue and earnings per share. All four divisions improved margins sequentially, with strong performance outside the Middle East. The comp...

Analyst Insights
Bullish
4 hours ago
Ares Capital offers 10%+ dividend yield and trades below book value, benefiting from rising rates.

Ares Capital offers 10%+ dividend yield and trades below book value, benefiting from rising rates.

Ares Capital (ARCC) is a Business Development Company providing a dividend yield above 10%, currently trading below its book value. Its portfolio is largely composed of floating-rate debt, which benefits from rising interest rates, supporting income ...

Analyst Insights
Bullish
4 hours ago
New Proof of Human feature links Alien ID to Solana wallets for real user verification.

New Proof of Human feature links Alien ID to Solana wallets for real user verification.

A new Proof of Human feature allows users to link an Alien ID to any Solana wallet, verifying that a real person controls the wallet. This initiative aims to enhance trust and security in blockchain transactions by confirming human identity behind wa...

Protocol Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App